Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
CNS & Neurological Disorders Drug Targets
|
March 25, 2015
Telomeric Repeat Containing RNA (TERRA): Aging and Cancer
Sonam Sinha, Samriddhi Shukla, Sajid Khan, et al.
The International Journal of Biochemistry & Cell Biology
|
December 3, 2014
Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling
Sajid Khan, Samriddhi Shukla, Sonam Sinha, et al.
Scientific Reports
|
February 25, 2016
Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis
Samriddhi Shukla, Sonam Sinha, Sajid Khan, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 28, 2015
Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis
Samriddhi Shukla, Sajid Khan, Sudhir Kumar, et al.
Life Sciences
|
June 21, 2020
Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis
Sajid Khan, Samriddhi Shukla, Mohammad Farhan, et al.
Molecular Biology of the Cell
|
April 30, 2020
FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation
Markaisa Black, Paritha Arumugam, Samriddhi Shukla, et al.
The International Journal of Biochemistry & Cell Biology
|
May 24, 2016
Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis
Sonam Sinha, Sajid Khan, Samriddhi Shukla, et al.
Frontiers in Oncology
|
May 1, 2023
Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma <i>via</i> the combination therapy with FOXM1 inhibitor RCM1
Johnny Donovan, Zicheng Deng, Fenghua Bian, et al.
Frontiers in Oncology
|
February 23, 2023
Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma <i>via</i> the combination therapy with FOXM1 inhibitor RCM1
Johnny Donovan, Zicheng Deng, Fenghua Bian, et al.
Journal of Medicinal Chemistry
|
April 4, 2015
Synthesis of β-Carboline-Based N-Heterocyclic Carbenes and Their Antiproliferative and Antimetastatic Activities against Human Breast Cancer Cells
Shashikant U Dighe, Sajid Khan, Isha Soni, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
CNS & Neurological Disorders Drug Targets
|
March 25, 2015
Telomeric Repeat Containing RNA (TERRA): Aging and Cancer
Sonam Sinha, Samriddhi Shukla, Sajid Khan, et al.
The International Journal of Biochemistry & Cell Biology
|
December 3, 2014
Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling
Sajid Khan, Samriddhi Shukla, Sonam Sinha, et al.
Scientific Reports
|
February 25, 2016
Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis
Samriddhi Shukla, Sonam Sinha, Sajid Khan, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 28, 2015
Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis
Samriddhi Shukla, Sajid Khan, Sudhir Kumar, et al.
Life Sciences
|
June 21, 2020
Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis
Sajid Khan, Samriddhi Shukla, Mohammad Farhan, et al.
Molecular Biology of the Cell
|
April 30, 2020
FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation
Markaisa Black, Paritha Arumugam, Samriddhi Shukla, et al.
The International Journal of Biochemistry & Cell Biology
|
May 24, 2016
Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis
Sonam Sinha, Sajid Khan, Samriddhi Shukla, et al.
Frontiers in Oncology
|
May 1, 2023
Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma <i>via</i> the combination therapy with FOXM1 inhibitor RCM1
Johnny Donovan, Zicheng Deng, Fenghua Bian, et al.
Frontiers in Oncology
|
February 23, 2023
Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma <i>via</i> the combination therapy with FOXM1 inhibitor RCM1
Johnny Donovan, Zicheng Deng, Fenghua Bian, et al.
Journal of Medicinal Chemistry
|
April 4, 2015
Synthesis of β-Carboline-Based N-Heterocyclic Carbenes and Their Antiproliferative and Antimetastatic Activities against Human Breast Cancer Cells
Shashikant U Dighe, Sajid Khan, Isha Soni, et al.
Page
of 3